Login: | Sitemap: | Search: |
Robert Penchovsky's Website
Robert's Publications
Robert's Patents
-
WO/2008/127382A2
-
US20110288826
-
WO/2018/197926A1
Methods for creating novel antibacterial agents using chimeric antisense oligonucleotides..
-
Bulgarian patent
News and Views on me
-
Nature Biotechnology
-
Nature Methods
-
ACS Synthetic Biology
-
RSC Chemistry World
Dear Visitor,
You can find here any research or news article I have published. It is provided full citation statistics for any research publication according to many different research databases. You can also find my Doctoral thesis, patents, and News and Views papers on my research. I am Review Editor in genetic systems and circuit design of Frontiers in Synthetic Biology and also Guest Editor of Special Issue "New Approaches in Antimicrobial Drug Discovery and Design" of the journal Antibiotics with impact factor 4.8.
Our recent paper is among the most popular in the ACS Synthetic Biology!
Recently, the research in the Robert Penchovsky laboratory was supported by a grant DN13/14/20.12.2017, completed with 20 publications with IF of 84 points and Q1-4 of 274 points entitled "Design and experimental validation of chimeric antisense oligonucleotides as antibacterial agents" and is currently supported by a grant KP-06-H31/18/13.12.2019 entitled "Engineering functional nucleic acids for synthetic control of gene expression in prokaryotes and eukaryotes" awarded by the Bulgarian National Science Fund (BNSF). You can see a presentation of the results of the first half of the project DN13/14/20.12.2017 (in Bulgarian only). Our research was noticed and commented in high impact factor journals such as Nature Biotechnology, Nature Methods, ACS Synthetic Biology, and RSC Chemistry World.
All publications presented herein, are in a PDF format. You can install the latest freely available version of Adobe Reader from here.
Citation statistics of my scientific publications: over 1400 citations;
Impact Factor: over 250 points; H-index: 18 points; I10-index: 25
My current citations according to GoogleScholar are 1409 indexing 66 publications and can be seen here. Since 2019, my scientific publications have been cited 805 times. The citations include research, reviews, and news and views articles, book chapters, patents, and Ph.D. theses. Currently, my H-index is equal to 17 points while my I10-index has 25 points according to ScholarGoogle. Since 2019, my H-index has 16 points and my I10-index has also 22 points.
I am a leading author (the first or the last author) of 97% of my publications and the corresponding author(*) of 94% of them! Moreover, 87% of all publications have not more than 3 co-authors and 11.4% of them have 4 or 5 co-authors. Only one publication has more than 5 co-authors (1.6%), namely 7. Since my assistant professorship position in 2010, I have published 14 papers of various types as a solid author and 43 papers only with my current or former master or doctoral students as co-authors. A list of 1231 citations of my publications without self-citations till the end of 22.03.2024 can be seen here. I have an Impact Factor (IF) of 254 points (see the slide show below).
My current citations according to ResearchGate are 1170 with H-index of 18 points indexing 70 publications (see on a mobile phone). My research has 26 highly influential citations and overall 1027 citations with a H-index of 17 points on SemanticScholar indexing 55 publications. According to Scopus are 993 citations by 690 documents with H-index of 17 points indexing 46 publications.
You can also follow my research on PubMed includes 29 publications, WoS includes 29 publications with H-index of 15 and 721 citations by 528 articles, NACID includes 107 publications, Mendeley includes 61 publications, Frontiers, and Academia, and ORCID includes 70 publications
Robert's research keywords: ribozymes, riboswitches, bioinformatics, biosensors, microfluidics, DNA/RNA computing, RNA synthetic biology, and rational drug design.
My publications and 3 News and Views papers! on my research,
* corresponding author:
Next